Trial no.:
|
PACTR201803003160262 |
Date of Approval:
|
03/03/2018 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Effectiveness of a six-week treatment course of vitamin D in steady state sickle cell anaemia children with hypovitaminosis |
Official scientific title |
Comparative Effectiveness of six-week treatment course of vitamin D2 and D3 in children with sickle cell anaemia in steady state: A randomized clinical Trial |
Brief summary describing the background
and objectives of the trial
|
A randomized clinical trial. A comparative study to determine the effectiveness of six-week treatment of hypovitaminosis in children with sickle cell anaemia using vitamin D2 and D2. The objectives are: To determine the difference in the mean serum rise of subjects treated with vitamin D2 and D3. Six-week treatment using 50,000IU weekly of vitamin D according to Endocrine society clinical practice guideline has been adopted for the study. Inclusion criteria includes confirmed Haemoglobin SS children aged one to eighteen years in steady state. Exclusion criteria are children on antituberculose drug, on anticonvulsants and with established liver or kidney disease.
The study also aimed to also determine the effect of correction of hypovitaminosis on serum calcium and alkaline phosphatase. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Haematological Disorders,Nutritional, Metabolic, Endocrine,Sickle cell anaemia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
11/03/2018 |
Actual trial start date |
11/03/2018 |
Anticipated date of last follow up |
31/05/2018 |
Actual Last follow-up date |
31/05/2018 |
Anticipated target sample size (number of participants) |
154 |
Actual target sample size (number of participants) |
148 |
Recruitment status |
Recruiting |
Publication URL |
|
|